New diabetes clinical trial: Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management

Published on: May 06, 2019 at 07:00PM
Conditions:   Cystic Fibrosis-related Diabetes;   Cystic Fibrosis Pulmonary Exacerbation;   Cystic Fibrosis in Children
Interventions:   Device: Sensor Augmented Pump Therapy;   Device: Standard of Care with CGM
Sponsors:   University of Colorado, Denver;   Cystic Fibrosis Foundation
Not yet recruiting